Here are a few of the most interesting Intercept Pharmaceuticals statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Intercept Pharmaceuticals Facts
- Website: Official Website
- Year Founded: 2002
- Headquarters: New York, NY
- Current Chief Executive: Mark Pruzanski
What is Intercept Pharmaceuticals?
We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. (source)
Intercept Pharmaceuticals Employee Count
Number of Intercept Pharmaceuticals employees:
Last updated 1/1/20
Intercept Pharmaceuticals Revenue Totals
Intercept Pharmaceuticals annual revenue:
- 2019: $252 million
- 2018: $179 million
- 2017: $130 million
- 2016: $24 million
- 2015: $2 million
Intercept Pharmaceuticals annual net income:
- 2019: $344 million net loss
- 2018: $309 million net loss
- 2017: $360 million net loss
- 2016: $412 million net loss
- 2015: $226 million net loss